Cardiology, Nephrology, and Endocrinology and Metabolism

Research Summary

The Department of Internal Medicine 2 was separated and became independent from the Department of Internal Medicine 1 in 1940, and now specializes in cardiovascular, renal, endocrine and metabolic diseases including all modern diseases: metabolic syndrome, acute coronary syndrome, chronic kidney disease, hypertension, and serious diabetes.
In the Division of Cardiological Medicine, we established a coronary care unit (CCU) in 1978. Now we manage an intensive heart care center in Takii and Hirakata and treat more than 1500 emergency patients of heart diseases per year. In addition to cardiac catheter inspection or percutaneous transluminal coronary angioplasty, we perform catheter ablation treatment for serious arrhythmia and biventricular pacing therapy for patients with serious heart failure. We perform early detection of diseases and decision making for the proper course of treatment by conducting more than 4000 ultrasound inspections of the heart per year, more than 1000 RI inspections per year, as well as coronary artery CT inspections using a multi detector-row CT and MRI inspections. Thus, we carry a heavy responsibility as a regional core hospital. The Division of Endocrine Metabolic Medicine treats over 1000 diabetic patients and conducts I131 isotope therapy of Basedow’s disease. The Division of Renal Medicine provides kidney protection measures for patients with chronic renal disease, whose number has been steadily increasing in recent years, and biopsy evidence-based medical care for treatment of acute and chronic nephropathy.